Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

700
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
700
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

371
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
371
Neural Regulation01:37

Neural Regulation

39.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiparametric MRI and imaging transcriptomics reveal molecular and cellular correlates of neurodegeneration in experimental Parkinsonism.

NPJ Parkinson's disease·2026
Same author

Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism.

Journal of neuroinflammation·2026
Same author

Transcriptional dysregulation in the cerebellum triggered by oligodendroglial α-synucleinopathy: insights from a transgenic mouse into the early disease mechanisms of MSA.

Journal of neural transmission (Vienna, Austria : 1996)·2025
Same author

Nigral Neuroinflammation and Dopaminergic Neurons in Parkinson's Disease and Atypical Parkinsonisms.

Annals of neurology·2025
Same author

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions.

Neuron·2025
Same author

Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusions.

Neuron·2024

Related Experiment Video

Updated: Sep 6, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.1K

Microglia in Parkinson's Disease.

Nadia Stefanova1

  • 1Laboratory for Translational Neurodegeneration Research, Division of Neurobiology, Department of Neurology, Medical University of Innsbruck, Austria.

Journal of Parkinson'S Disease
|June 27, 2022
PubMed
Summary
This summary is machine-generated.

Microglia, the brain's immune cells, play a dual role in Parkinson's disease (PD) pathogenesis by clearing and spreading toxic alpha-synuclein. Understanding microglial heterogeneity offers new therapeutic targets for PD.

Keywords:
Alpha-synucleinPETParkinson’s diseasebiomarkerdisease modifying therapymicrogliamultiple system atrophyneuroinflammatory

More Related Videos

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.9K
Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

4.2K

Related Experiment Videos

Last Updated: Sep 6, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.1K
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.9K
Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes
11:19

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

4.2K

Area of Science:

  • Neuroimmunology
  • Neurodegeneration
  • Central Nervous System (CNS) research

Background:

  • Microglia are the primary immune cells in the CNS.
  • Increased microglial activation is observed in neurodegenerative disorders like Parkinson's disease (PD).
  • Microglia are increasingly recognized for their role in PD pathogenesis and alpha-synucleinopathies.

Purpose of the Study:

  • To review recent findings (last 3 years) on microglia in PD.
  • To elucidate microglial heterogeneity and their dual role in PD.
  • To examine microglia's interaction with pathological alpha-synuclein.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of studies focusing on microglial function in PD.
  • Synthesis of data on alpha-synuclein clearance and spreading mediated by microglia.

Main Results:

  • Microglia exhibit significant heterogeneity in their activation states and functions in PD.
  • Microglia demonstrate a dual role: mediating both clearance and propagation of pathological alpha-synuclein.
  • Specific microglial interactions with alpha-synuclein strains are crucial for disease progression.

Conclusions:

  • Microglia are central players in PD pathogenesis, influencing both disease initiation and progression.
  • Microglial heterogeneity presents a complex but promising area for therapeutic intervention in PD.
  • Microglia represent a potential biomarker and therapeutic target for Parkinson's disease and related disorders.